Screen young, healthy infertile men for possible erectile dysfunction

Young, healthy infertile men should be screenedfor possible erectile dysfunction since infertility may be the first andonly indication of an endocrine abnormality, according to researchers fromthe University of Toronto.

Related Videos

Related Content

Advertisement

December 10th 2024

Quiz: CUA guidelines on germline genetic testing in prostate cancer

Urology Times staff

Test your knowledge of his quiz the Canadian Urological Association's recommendations for germline genetic testing in prostate cancer management.

November 27th 2024

Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD

Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

December 9th 2024

FDA grants clearance to NanoKnife System for prostate tissue ablation

Hannah Clarke

The clearance is supported by data from the PRESERVE trial, which evaluated the safety and effectiveness of the NanoKnife System in patients with intermediate-risk prostate cancer.

November 15th 2024

Former MLB player Dave Winfield shares lessons from baseball, philanthropy

Urology Times staff

In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.

December 6th 2024

Gemcitabine-BCG shows early promise in BCG-exposed NMIBC

Benjamin P. Saylor

CR rate was 98% (39/40) at 3 months, 94% at 6 months (34/36), and 81% at 12 months (21/26).

December 6th 2024

FDA grants priority review to durvalumab for muscle-invasive bladder cancer

Benjamin P. Saylor

The priority review decision is based on results of the phase 3 NIAGARA study (NCT03732677).

Related Content

Advertisement

December 10th 2024

Quiz: CUA guidelines on germline genetic testing in prostate cancer

Urology Times staff

Test your knowledge of his quiz the Canadian Urological Association's recommendations for germline genetic testing in prostate cancer management.

November 27th 2024

Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD

Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

December 9th 2024

FDA grants clearance to NanoKnife System for prostate tissue ablation

Hannah Clarke

The clearance is supported by data from the PRESERVE trial, which evaluated the safety and effectiveness of the NanoKnife System in patients with intermediate-risk prostate cancer.

November 15th 2024

Former MLB player Dave Winfield shares lessons from baseball, philanthropy

Urology Times staff

In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.

December 6th 2024

Gemcitabine-BCG shows early promise in BCG-exposed NMIBC

Benjamin P. Saylor

CR rate was 98% (39/40) at 3 months, 94% at 6 months (34/36), and 81% at 12 months (21/26).

December 6th 2024

FDA grants priority review to durvalumab for muscle-invasive bladder cancer

Benjamin P. Saylor

The priority review decision is based on results of the phase 3 NIAGARA study (NCT03732677).